Carthera

CARTHERA developed the SonoCloud, a clinical stage intracranial implant that temporarily opens the blood-brain barrier (BBB). By increasing the permeability of the cerebral blood vessels using low intensity pulsed ultrasound, the concentration of therapeutic molecules that reach the brain can be increased by up to seven times and their efficacy dramatically improved. SonoCloud device may notably be used with investigational or commercialized pharmaceutical agents with the goal to better treat brain diseases. CarThera is thus looking for collaborations with pharmaceutical companies or biotech interested in evaluating the combined use of their agents with its device.